Provided by Tiger Fintech (Singapore) Pte. Ltd.

Legend Biotech

41.59
-0.5400-1.28%
Post-market: 42.090.5000+1.20%19:16 EDT
Volume:1.46M
Turnover:61.74M
Market Cap:7.66B
PE:-34.94
High:43.75
Open:42.46
Low:41.19
Close:42.13
Loading ...

Legend Biotech (LEGN) Receives a Buy from Goldman Sachs

TIPRANKS
·
17 Jul

Strong Growth and Competitive Advantage Drive Buy Rating for Legend Biotech

TIPRANKS
·
17 Jul

BUZZ-GenScript Biotech jumps on associate's Carvykti sales beat

Reuters
·
17 Jul

BUZZ-U.S. STOCKS ON THE MOVE-Commvault Systems, Rockwell Automation, Tesla

Reuters
·
17 Jul

BUZZ-U.S. STOCKS ON THE MOVE-Legend Biotech, Unity Software, MP Materials

Reuters
·
16 Jul

BUZZ-Legend Biotech up as Q2 sales for J&J-partnered blood cancer therapy rises

Reuters
·
16 Jul

Legend Biotech Reports Strong CARVYKTI® Sales for Q2 2025

TIPRANKS
·
16 Jul

Legend Biotech Reports $439 Million in Net Trade Sales for CARVYKTI® in Q2 2025

Reuters
·
16 Jul

Legend Biotech Is Maintained at Overweight by Morgan Stanley

Dow Jones
·
11 Jul

Legend Biotech price target raised to $81 from $80 at Morgan Stanley

TIPRANKS
·
10 Jul

Exclusive-U.S. Lawmakers Renew Their Concerns About Genscript's Ties to China in a Letter to the Fbi's Director and the Director of National Intelligence

THOMSON REUTERS
·
09 Jul

Legend Biotech Price Target Maintained With a $75.00/Share by HC Wainwright & Co.

Dow Jones
·
08 Jul

Positive Growth Outlook for Legend Biotech Driven by Carvykti Sales and Strategic Expansion

TIPRANKS
·
08 Jul

Strong Buy Rating for Legend Biotech’s CARVYKTI Amid Limited Competition and Favorable Risk Profile

TIPRANKS
·
08 Jul

Legend Biotech (LEGN) Receives a Buy from RBC Capital

TIPRANKS
·
08 Jul

RBC Lowers Price Target on Legend Biotech to $75 From $78, Keeps Outperform Rating

MT Newswires Live
·
07 Jul

UBS Lowers Price Target on Legend Biotech to $54 From $60, Maintains Buy Rating

MT Newswires Live
·
03 Jul

Legend Biotech Is Maintained at Buy by UBS

Dow Jones
·
03 Jul

Promising Outlook for Legend Biotech’s CARVYKTI: Buy Rating Affirmed by Mitchell Kapoor

TIPRANKS
·
02 Jul

Legend Biotech’s CAR T Cell Therapies See FDA REMS Removal and EMA Label Update

TIPRANKS
·
01 Jul